Table 4.
Details of mono, dual, triple, or quadruple therapy prescribed.
| Type of Drug Therapy | Drug Name | No. of Patients [n = 150 (%)] |
|---|---|---|
| Monotherapy | 70 (46.6) | |
| One antidepressant (n = 40, 26.6%) | Amitriptyline | 14 (9.3) |
| Escitalopram | 13 (8.6) | |
| Sertraline | 6 (4) | |
| Fluoxetine | 4 (2.6) | |
| Desvenlafaxine | 1 (0.6) | |
| Imipramine | 1 (0.6) | |
| Mirtazapine | 1 (0.6) | |
| One psychotropic drug (n = 30, 20%) | Clonazepam | 8 (5.3) |
| Risperidone | 8 (5.3) | |
| Quetiapine | 6 (4) | |
| Aripiprazole | 3 (2) | |
| Olanzapine | 2 (1.3) | |
| Amisulpride | 2 (1.3) | |
| Lithium | 1 (0.6) | |
| Dual therapy | 69 (46) | |
| Two antidepressants (n = 13, 8.6%) | Escitalopram and amitriptyline | 9 (6) |
| Sertraline and amitriptyline | 2 (1.3) | |
| Escitalopram and mirtazapine | 1 (0.6) | |
| Paroxetine and amitriptyline | 1 (0.6) | |
| Two psychotropic drugs (n = 7, 4.6%) | Clonazepam and risperidone | 1 (0.6) |
| Rasagiline and donepezil | 1 (0.6) | |
| Quetiapine and aripiprazole | 1 (0.6) | |
| Amisulpride and aripiprazole | 1 (0.6) | |
| Olanzapine and lithium | 1 (0.6) | |
| Olazapine and clobazam | 1 (0.6) | |
| Clobazam and donepezil | 1 (0.6) | |
| One antidepressant and one psychotropic drug (n = 39, 26%) | Sertraline and clonazepam | 8 (5.3) |
| Escitalopram and clonazepam | 6 (4) | |
| Escitalopram and aripiprazole | 4 (2.6) | |
| Sertraline and risperidone | 4 (2.6) | |
| Fluoxetine and clonazepam | 2 (1.3) | |
| Duloxetine and quetiapine | 2 (1.3) | |
| Escitalopram and lithium | 2 (1.3) | |
| Amitriptyline and clonazepam | 1 (0.6) | |
| Duloxetine and clonazepam | 1 (0.6) | |
| Paroxetine and aripiprazole | 1 (0.6) | |
| Sertraline and amisulpride | 1 (0.6) | |
| Paroxetine and amisulpride | 1 (0.6) | |
| Fluoxetine and zolpidem | 1 (0.6) | |
| Escitalopram and olanzapine | 1 (0.6) | |
| Sertraline and olanzapine | 1 (0.6) | |
| Amitriptyline and olanzapine | 1 (0.6) | |
| Escitalopram and clobazam | 1 (0.6) | |
| Amitriptyline and clobazam | 1 (0.6) | |
| Combination therapy (n = 10, 6.6%) | Desvenalafaxine + clonazepam | 3 (2) |
| Escitalopram + clonazepam | 3 (2) | |
| Risperidone + trihexyphenidyl | 2 (1.3) | |
| Amitriptyline + chlordiazepoxide | 2 (1.3) | |
| Triple therapy | 10 (6.6) | |
| Two antidepressants and one psychotropic drug (n = 1, 0.6%) | Sertraline, fluoxetine and clonazepam | 1 (0.6) |
| One antidepressant and two psychotropic drug (n = 4, 2.6%) | Fluoxetine, donepezil and risperidone | 1 (0.6) |
| Sertraline, clonazepam and risperidone | 1 (0.6) | |
| Sertraline, clonazepam and olanzapine | 1 (0.6) | |
| Paroxetine, clonazepam and aripiprazole | 1 (0.6) | |
| One combination therapy and one antidepressant (n = 5, 3.3%) | Escitalopram + clonazepam and amitriptyline | 2 (1.3) |
| Paroxetine + clonazepam and amitriptyline | 1 (0.6) | |
| Paroxetine + clonazepam and amitriptyline | 1 (0.6) | |
| Risperidone + trihexyphenidyl and sertraline | 1 (0.6) | |
| Quadruple therapy (n = 1, 0.6%) | Risperidone + trihexyphenidyl, quetiapine, and lithium | 1 (0.6) |